Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

U.K.’s MHRA Moves To Implement Restrictions On Prexige Prescribing

Related Content

FDA Cold-Cox Merck; Arcoxia “Not Approvable” For Osteoarthritis

Apr 27 2007

Novartis Withdraws Prexige In Australia Ahead Of FDA Decision Due To Deaths

Aug 13 2007

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window